J&J to buy surgical robotics company for $3.4bn
18-02-2019
J&J plans to sell LifeScan for $2.1bn
21-03-2018
pyotr021 / iStockphoto.com
Johnson & Johnson (J&J) has revealed plans to strengthen its medical device capabilities with the acquisition of French medical technology company Orthotaxy.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Johnson & Johnson, Orthotaxy, DePuy Synthes, robotic surgery, med tech developments, digital healthcare, medical innovation, surgery patents, orthopaedic
